Massachusetts lawmakers, and specifically the state’s Board of Registration in Pharmacy, have been under increased scrutiny following the deadly meningitis outbreak that occurred last year.
Prior to the outbreak, the regulators changed course regarding a decision to shut down a Massachusetts pharmacy whose medication error sent a teenager to the emergency room with a heart attack. While they claim to still be investigating, they have yet to take disciplinary action against the responsible pharmacy.
According to state records, in July of 2011 Royal Palm Specialty Pharmacy reportedly accidentally gave a patient thyroid medication that was 1,000 times too concentrated. This devastating error required hospitalization for serious heart complications. The board reportedly only found out about the error after the boy’s mother called to complain, four months later.
According to state documents, instead of supplying 10 microgram capsules of the relevant thyroid medication, the pharmacy apparently provided capsules containing 10,000 micrograms.
After taking the drug, the teenager had to be taken to an emergency room four times and hospitalized twice in August 2011 for heart problems. The symptoms still plague the young man, as he reportedly continues to experience generalized weakness and heart palpitations.
Investigators found that the pharmacy did not report the overdose to the state board, even though they are required to report any errors that lead to death or serious injury within 15 days. A pharmacist for the company says that she did not report the error, because she did not know the extent of the harm to the young man, as she could not get in touch with his mother. The pharmacist has since been reprimanded by the state for the error.